U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Refractory Fallopian Tube Adenocarcinoma

MedGen UID:
1770398
•Concept ID:
C5418914
•
Neoplastic Process

Definition

Fallopian tube adenocarcinoma that is resistant to treatment. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRefractory Fallopian Tube Adenocarcinoma

Professional guidelines

PubMed

Personalized cancer treatment for ovarian cancer.
Chumworathayi B
Asian Pac J Cancer Prev 2013;14(3):1661-4. doi: 10.7314/apjcp.2013.14.3.1661. PMID: 23679252
SOGC clinical guidelines. Hysterectomy.
Lefebvre G, Allaire C, Jeffrey J, Vilos G, Arneja J, Birch C, Fortier M; Clinical Practice Gynaecology Committee and Executive Committeee and Council, Society of Obstetricians and Gynaecologists of Canada
J Obstet Gynaecol Can 2002 Jan;24(1):37-61; quiz 74-6. PMID: 12196887

Recent clinical studies

Etiology

A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283.
O'Cearbhaill RE, Miller A, Soslow RA, Lankes HA, DeLair D, Segura S, Chavan S, Zamarin D, DeBernardo R, Moore K, Moroney J, Shahin M, Thaker PH, Wahner-Hendrickson AE, Aghajanian C
Gynecol Oncol 2023 Sep;176:16-24. Epub 2023 Jul 5 doi: 10.1016/j.ygyno.2023.06.021. PMID: 37418832Free PMC Article
HIPEC after neoadjuvant chemotherapy and interval debulking is associated with development of platinum-refractory or -resistant disease.
Jou J, Zimmer Z, Charo L, Yau C, Saenz C, Eskander R, McHale M, Veerapong J, Plaxe S, Binder P
Gynecol Oncol 2021 Apr;161(1):25-33. Epub 2020 Dec 6 doi: 10.1016/j.ygyno.2020.11.035. PMID: 33293046
Personalized cancer treatment for ovarian cancer.
Chumworathayi B
Asian Pac J Cancer Prev 2013;14(3):1661-4. doi: 10.7314/apjcp.2013.14.3.1661. PMID: 23679252
Phase II study of gefitinib in combination with paclitaxel (P) and carboplatin (C) as second-line therapy for ovarian, tubal or peritoneal adenocarcinoma (1839IL/0074).
Pautier P, Joly F, Kerbrat P, Bougnoux P, Fumoleau P, Petit T, Rixe O, Ringeisen F, Carrasco AT, Lhommé C
Gynecol Oncol 2010 Feb;116(2):157-62. doi: 10.1016/j.ygyno.2009.10.076. PMID: 20109725
SOGC clinical guidelines. Hysterectomy.
Lefebvre G, Allaire C, Jeffrey J, Vilos G, Arneja J, Birch C, Fortier M; Clinical Practice Gynaecology Committee and Executive Committeee and Council, Society of Obstetricians and Gynaecologists of Canada
J Obstet Gynaecol Can 2002 Jan;24(1):37-61; quiz 74-6. PMID: 12196887

Diagnosis

Spontaneous resolution of dermatomyositis associated with fallopian-tube carcinoma following staging surgery: A case report.
Lin C, Ying Z, Sijing C
Medicine (Baltimore) 2019 Mar;98(10):e14530. doi: 10.1097/MD.0000000000014530. PMID: 30855437Free PMC Article
Phase II study of gefitinib in combination with paclitaxel (P) and carboplatin (C) as second-line therapy for ovarian, tubal or peritoneal adenocarcinoma (1839IL/0074).
Pautier P, Joly F, Kerbrat P, Bougnoux P, Fumoleau P, Petit T, Rixe O, Ringeisen F, Carrasco AT, Lhommé C
Gynecol Oncol 2010 Feb;116(2):157-62. doi: 10.1016/j.ygyno.2009.10.076. PMID: 20109725
Cryptococcosis masquerading as a tuboovarian abscess.
Sing Y, Ramdial PK, Ibrahim T
Int J Gynecol Pathol 2008 Jan;27(1):37-40. doi: 10.1097/pgp.0b013e318093fa11. PMID: 18156972
A case of uterine endometrial carcinoma 15 months post-partum.
Ishioka S, Sagae S, Saito T, Sugimura M, Akutagawa N, Nishimura M, Ezaka Y, Kudo R
J Obstet Gynaecol Res 2000 Dec;26(6):417-20. doi: 10.1111/j.1447-0756.2000.tb01351.x. PMID: 11152326

Therapy

A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283.
O'Cearbhaill RE, Miller A, Soslow RA, Lankes HA, DeLair D, Segura S, Chavan S, Zamarin D, DeBernardo R, Moore K, Moroney J, Shahin M, Thaker PH, Wahner-Hendrickson AE, Aghajanian C
Gynecol Oncol 2023 Sep;176:16-24. Epub 2023 Jul 5 doi: 10.1016/j.ygyno.2023.06.021. PMID: 37418832Free PMC Article
HIPEC after neoadjuvant chemotherapy and interval debulking is associated with development of platinum-refractory or -resistant disease.
Jou J, Zimmer Z, Charo L, Yau C, Saenz C, Eskander R, McHale M, Veerapong J, Plaxe S, Binder P
Gynecol Oncol 2021 Apr;161(1):25-33. Epub 2020 Dec 6 doi: 10.1016/j.ygyno.2020.11.035. PMID: 33293046
Personalized cancer treatment for ovarian cancer.
Chumworathayi B
Asian Pac J Cancer Prev 2013;14(3):1661-4. doi: 10.7314/apjcp.2013.14.3.1661. PMID: 23679252
Phase II study of gefitinib in combination with paclitaxel (P) and carboplatin (C) as second-line therapy for ovarian, tubal or peritoneal adenocarcinoma (1839IL/0074).
Pautier P, Joly F, Kerbrat P, Bougnoux P, Fumoleau P, Petit T, Rixe O, Ringeisen F, Carrasco AT, Lhommé C
Gynecol Oncol 2010 Feb;116(2):157-62. doi: 10.1016/j.ygyno.2009.10.076. PMID: 20109725
SOGC clinical guidelines. Hysterectomy.
Lefebvre G, Allaire C, Jeffrey J, Vilos G, Arneja J, Birch C, Fortier M; Clinical Practice Gynaecology Committee and Executive Committeee and Council, Society of Obstetricians and Gynaecologists of Canada
J Obstet Gynaecol Can 2002 Jan;24(1):37-61; quiz 74-6. PMID: 12196887

Prognosis

A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283.
O'Cearbhaill RE, Miller A, Soslow RA, Lankes HA, DeLair D, Segura S, Chavan S, Zamarin D, DeBernardo R, Moore K, Moroney J, Shahin M, Thaker PH, Wahner-Hendrickson AE, Aghajanian C
Gynecol Oncol 2023 Sep;176:16-24. Epub 2023 Jul 5 doi: 10.1016/j.ygyno.2023.06.021. PMID: 37418832Free PMC Article
Salvage chemotherapy in recurrent platinum-resistant or refractory epithelial ovarian cancer with Carboplatin and distearoylphosphatidylcholine pegylated liposomal Doxorubicin (lipo-dox®).
Khemapech N, Oranratanaphan S, Termrungruanglert W, Lertkhachonsuk R, Vasurattana A
Asian Pac J Cancer Prev 2013;14(3):2131-5. doi: 10.7314/apjcp.2013.14.3.2131. PMID: 23679331
Personalized cancer treatment for ovarian cancer.
Chumworathayi B
Asian Pac J Cancer Prev 2013;14(3):1661-4. doi: 10.7314/apjcp.2013.14.3.1661. PMID: 23679252
A phase I study of oral topotecan and pegylated liposomal doxorubicin (doxil) in platinum-resistant ovarian and peritoneal cancer.
Rose PG, Smrekar M, Haba P, Fusco N, Rodriguez M
Am J Clin Oncol 2008 Oct;31(5):476-80. doi: 10.1097/COC.0b013e31816a6221. PMID: 18838885
SOGC clinical guidelines. Hysterectomy.
Lefebvre G, Allaire C, Jeffrey J, Vilos G, Arneja J, Birch C, Fortier M; Clinical Practice Gynaecology Committee and Executive Committeee and Council, Society of Obstetricians and Gynaecologists of Canada
J Obstet Gynaecol Can 2002 Jan;24(1):37-61; quiz 74-6. PMID: 12196887

Clinical prediction guides

A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283.
O'Cearbhaill RE, Miller A, Soslow RA, Lankes HA, DeLair D, Segura S, Chavan S, Zamarin D, DeBernardo R, Moore K, Moroney J, Shahin M, Thaker PH, Wahner-Hendrickson AE, Aghajanian C
Gynecol Oncol 2023 Sep;176:16-24. Epub 2023 Jul 5 doi: 10.1016/j.ygyno.2023.06.021. PMID: 37418832Free PMC Article
Spontaneous resolution of dermatomyositis associated with fallopian-tube carcinoma following staging surgery: A case report.
Lin C, Ying Z, Sijing C
Medicine (Baltimore) 2019 Mar;98(10):e14530. doi: 10.1097/MD.0000000000014530. PMID: 30855437Free PMC Article
A phase I study of oral topotecan and pegylated liposomal doxorubicin (doxil) in platinum-resistant ovarian and peritoneal cancer.
Rose PG, Smrekar M, Haba P, Fusco N, Rodriguez M
Am J Clin Oncol 2008 Oct;31(5):476-80. doi: 10.1097/COC.0b013e31816a6221. PMID: 18838885
SOGC clinical guidelines. Hysterectomy.
Lefebvre G, Allaire C, Jeffrey J, Vilos G, Arneja J, Birch C, Fortier M; Clinical Practice Gynaecology Committee and Executive Committeee and Council, Society of Obstetricians and Gynaecologists of Canada
J Obstet Gynaecol Can 2002 Jan;24(1):37-61; quiz 74-6. PMID: 12196887

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...